• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC REDIGUARD IAB: 8FR 50CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL LLC REDIGUARD IAB: 8FR 50CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Model Number IPN038265
Medical Device Problem Code Inflation Problem (1310)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/28/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).There is an investigation ongoing into this reported complaint.A supplement follow-up mdr report will be submitted with the investigation results upon completion of the investigation.
 
Event or Problem Description
It was reported by the clinical support specialist (css) that the iab was inserted without difficulty or incident, when the staff attempted to initiate pumping, high pressure alarms occurred x2.There were no noted kinks and the iab appeared to not unwrap under fluoroscopy.The md opted to exchange the iab.A second iab was inserted in the same site.There was minimal delay and the patient remained stable throughout.
 
Event or Problem Description
It was reported by the clinical support specialist (css) that the iab was inserted without difficulty or incident, when the staff attempted to initiate pumping, high pressure alarms occurred x2.There were no noted kinks and the iab appeared to not unwrap under fluoroscopy.The md opted to exchange the iab.A second iab was inserted in the same site.There was minimal delay and the patient remained stable throughout.
 
Additional Manufacturer Narrative
(b)(4).Teleflex received the device for investigation.The reported complaint of iab would not inflate completely is not confirmed.The returned intra-aortic balloon catheter (iabc) bladder was fully intact with no abnormalities noted.The returned device passed visual and functional test specifications.The root cause of the complaint is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revised risk.This will be monitored for any developing trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REDIGUARD IAB: 8FR 50CC
Common Device Name
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL LLC
morrisville NC
Manufacturer (Section G)
ARROW INTERNATIONAL INC.
16 elizabeth drive
chelmsford MA 01824
Manufacturer Contact
kaylia pen
16 elizabeth drive
chelmsford, MA 01824
MDR Report Key13967116
Report Number3010532612-2022-00085
Device Sequence Number4163635
Product Code DSP
UDI-Device Identifier10801902144208
UDI-Public10801902144208
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K010330
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2022
Device Model NumberIPN038265
Device Catalogue NumberIAB-S850C
Device Lot Number18F20M0051
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/08/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/01/2022
Supplement Date Received by Manufacturer04/20/2022
Initial Report FDA Received Date03/31/2022
Supplement Report FDA Received Date04/22/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/16/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NI.; NI.
Patient SexMale
-
-